Profound Medical Sees FY2026 Sales $25.000M vs $26.858M Est

Benzinga Newsdesk www.benzinga.com Positive 72.3%

Neg 0% Neu 0% Pos 72.3%

Profound Medical (TSX:PRN) sees FY2026 sales of $25.000 million vs $26.858 million analyst estimate.

Comments

No comments yet. Be the first!